Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04416269 · ClinicalTrials.gov registry record · Phase 4
Oral Anti Diabetic Agents in the Hospital
A Phase 4 study of Diabetes Mellitus, sponsored by Emory University.
- Active
- Registry status
- Phase 4
- Development phase
- 255
- Enrollment target
- 3
- Study locations
NCT04416269 is a Phase 4 study of Diabetes Mellitus that is active but no longer recruiting, run by Emory University. The registered enrollment target is 255 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (86% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT04416269, a Phase 4 study of Diabetes Mellitus, is active but no longer recruiting, sponsored by Emory University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 255 participants
- Enrollment target
- 3
- Study locations
Study Summary
This randomized controlled clinical trial will assess whether continuation of home oral antidiabetic agents during hospitalization can be used as a safe and effective alternative to insulin therapy in the management of diabetes in the hospital. The primary outcome of the study is to determine differences in glycemic control as measured by mean daily blood glucose concentration between oral antidiabetic medications and basal bolus therapy in hospitalized patients with type 2 diabetes (T2D).
Conditions Studied
Interventions
- DRUG Oral Anti-diabetes Drugs alone
- DRUG Basal bolus insulin
- DRUG Supplemental insulin
- DEVICE Continuous glucose monitoring (CGM)
Study Locations (3)
Georgia
- Emory University Hospital Midtown - Atlanta
- Emory University Hospital - Atlanta
- Grady Memorial Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2020-08-07 |
| Est. Completion | 2026-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04416269
The ClinicalTrials.gov registry entry for NCT04416269 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (86% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 4 interventions - of which Oral Anti-diabetes Drugs alone is the first listed.
NCT04416269 reports 3 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT04416269 about?
NCT04416269 is a clinical study titled "Oral Anti Diabetic Agents in the Hospital". This randomized controlled clinical trial will assess whether continuation of home oral antidiabetic agents during hospitalization can be used as a safe and effective alternative to insulin therapy in the management of diabetes in the hospital. The primary outcome of the study is to determine differ...
What is the current status of trial NCT04416269?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 255 participants. The study started on 2020-08-07. Estimated completion is 2026-03.
What conditions does trial NCT04416269 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT04416269?
The interventions under investigation include: Oral Anti-diabetes Drugs alone (DRUG), Basal bolus insulin (DRUG), Supplemental insulin (DRUG), Continuous glucose monitoring (CGM) (DEVICE).
Who is sponsoring clinical trial NCT04416269?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04416269 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact GLP-1 Agonists Following Bariatric
RECRUITING · Phase 4
-
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
ACTIVE NOT RECRUITING · Phase 4
-
The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients
COMPLETED · Phase 4
-
Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction
COMPLETED · Phase 4
-
Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.
COMPLETED · Phase 4
-
A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.